| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11029140 | Oral Oncology | 2018 | 10 Pages |
Abstract
Collectively, our results demonstrated that CD44v4 expression is more linked with ERK1/2 activation and promote cisplatin resistance, whereas CD44v6 expression is associated primarily with PI3K/Akt/GSK3β activation and driving tumor invasion/migration.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Tanushree Kashyap, Kamdeo K. Pramanik, Nidhi Nath, Prajna Mishra, Abhay K. Singh, Siddhavaram Nagini, Ajay Rana, Rajakishore Mishra,